General Statement of Disclosure:

CONSULTING FEES/HONORARIA: United Therapeutics(MODEST), Medtronic(MODEST), Gradient(MODEST), Edwards LifeSciences(SIGNIFICANT), Acceleron(SIGNIFICANT), Acorai(MODEST), Abbott(SIGNIFICANT), Alleviant(MODEST), Cytokinetics(MODEST), Morphic Therapeutics(MODEST), Endotronix(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Aria CV(MODEST) OTHER FINANCIAL BENEFIT: Abiomed(SIGNIFICANT), Merck(SIGNIFICANT)

View Full Disclosure